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Cervical cancer is the second most common cancer to affect women 
globally, with 527 624 new cases and 265 672 deaths from the disease 
annually.[1] The age-standardised incidence rate was reported as 
31.7/100 000 for South Africa (SA) in 2014.[1] It has been shown 
previously that human papillomavirus (HPV) plays an important role 
in the development of precancerous lesions and their progression to 
cancer.[2] In addition, development of cervical cancer has been found 
to be associated with an early sexual debut, multiple sexual partners, 
smoking, and extended use of oral contraceptives.[3]
The association between HIV and invasive cervical cancer (ICC) 
is complex, with several studies now demonstrating an increased 
risk of preinvasive cervical lesions among HIV-positive women.[2,4] 
HIV-positive women with more advanced immunosuppression (CD4 
count <200 cells/µL) seem to be particularly vulnerable to infection 
with persistence of the high-risk HPV types that can lead to cancer.[4] 
Previous studies have found a significantly higher prevalence of HPV 
among HIV-positive women compared with HIV-negative women 
(87% v. 54% in Burkina Faso and 80% v. 50% in Zambia), and an 
increased prevalence of high-risk HPV types (71% v. 40% in Burkina 
Faso and 70% v. 35% in Zambia).[5,6] SA has the highest burden of 
HIV globally, with an estimated 4 million women living with HIV.[7] 
Because of the increased risk of acquiring HPV among women who 
are HIV-positive, after 2010 the national HIV treatment guidelines 
included specific guidance for cervical cancer screening.[8]
For a national approach to cervical cancer screening to work, 
women need to be aware of cervical cancer and the associated risk 
factors, as well as the screening and treatment services available to 
them. If they are not aware of the disease and associated risks, they 
will not seek timely screening or treatment services and are therefore 
at an increased risk of poor health outcomes.[9,10]
Screening behaviour and general health-seeking behaviour related 
to prevention services have not been widely studied among HIV-
positive women in SA, especially in the area of perceived risk 
and prevention screening practice in the era of increased life 
expectancy due to combination antiretroviral therapy (cART). Many 
of the studies involving cervical cancer and HIV-positive women in 
southern Africa focus on clinical aspects related to both diseases, 
as opposed to behavioural aspects such as women’s cervical cancer 
screening practice.
Objective
To examine awareness, perceived risk and practices related to cervical 
cancer screening among HIV-positive women in an urban HIV clinic 
in Johannesburg, SA.
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Background. Cervical cancer is a major cause of cancer-related deaths, especially in the context of the HIV epidemic.
Objective. To examine awareness, perceived risk and practices related to cervical cancer screening among HIV-positive women.
Methods. Interviewer-administered structured questionnaires were administered to HIV-positive women (aged ≥18 years) enrolled in a 
cervical cancer screening study at the Themba Lethu Clinic, Johannesburg, South Africa, from November 2009 to December 2011. Modified 
Poisson regression with robust standard errors was used to identify factors at enrolment associated with awareness, perceived risk and 
adequate practice related to cervical screening. Adjusted relative risks (aRRs) with 95% confidence intervals (CIs) are presented.
Results. Of the 1 202 women enrolled, 71.3% and 18.2% were aware of the Pap smear and HPV, respectively. Of the 1 192 participants with 
data evaluated, 76.5% were worried and 23.5% were not worried about cervical cancer; 28.6% of the women had adequate screening practice. 
Older age (40 - 49 years or ≥50 years v. 18 - 29 years) (aRR 1.63, 95% CI 1.12 - 2.37; aRR 2.22, 95% CI 1.44 - 3.41), higher education (tertiary 
v. less than grade 10) (aRR 1.39, 95% CI 1.00 - 1.93), initiation on combination antiretroviral therapy (aRR 1.36, 95% CI 1.00 - 1.85) and 
awareness of Pap smear screening (aRR 16.18, 95% CI 7.69 - 34.01) were associated with adequate screening practice.
Conclusions. High levels of Pap smear awareness and low levels of Pap smear screening uptake were observed. However, Pap smear 
awareness was associated with adequate screening practice. More research into effective health education programmes to address these 
gaps is needed.
S Afr Med J 2016;106(12):1247-1253. DOI:10.7196/SAMJ.2016.v106i12.11224
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Methods
Study site and participants
In April 2005, the non-governmental organisation Right to Care, 
in partnership with the SA government, established a cervical 
cancer screening and treatment centre alongside the HIV care, 
management and treatment facility at Themba Lethu Clinic, situated 
in a tertiary hospital in Johannesburg. A cervical cancer screening 
study (Validation of Implementation of Cervical Cancer Screening 
Applications in HIV-seropositive Women, VICAR 1) evaluating visual 
inspection with acetic acid, a standard Pap smear and HPV detection 
was performed at this centre. A questionnaire was administered by 
study staff. The primary results have been published.[11]
HIV-positive women aged 18 - 65 years who were eligible to 
participate, enrolled into the primary study (VICAR 1) from 
November 2009 to December 2011, not pregnant at the time of 
enrolment and signed an informed consent form were included.
Cervical cancer screening guidelines
The conventional Papanicolaou (Pap) smear for cervical cancer 
screening is used in the SA public health system.[12]
The guidelines for the management of HIV/AIDS released by 
the SA National Department of Health in 2010[8] (applicable to the 
women in the study) states that all HIV-positive women need cervical 
cancer screening on diagnosis of HIV. If this test is negative, they are 
then screened every 3 years, irrespective of prior initiation cART 
status. If results are abnormal, the guidelines recommend a repeat 
Pap smear or referral for further investigation or treatment.[8]
Data sources
In the primary study, participants answered an interviewer-
administered structured questionnaire containing coded questions 
about their medical, social and sexual history. The questionnaire 
also included a section that examined awareness, perceived risk and 
practices concerning cervical cancer and cervical cancer screening. 
The interviews were administered by trained female interviewers 
in the local languages, as appropriate. After the interview, women 
were provided with an education session that included information 
regarding cervical cancer and cervical cancer screening and treatment.
We conducted a cross-sectional study of these data for our study. 
Our study made use of all data collected as at the end of December 
2011, which included all 1 202 study participants.
Study definitions
Self-reported alcohol use, smoking or taking snuff (fine-ground 
tobacco intended for consumption by being inhaled or sniffed into 
the nose) denoted current use. Frequency of smoking and taking 
snuff was categorised according to the number of times the woman 
took snuff or the number of cigarettes smoked daily (<5 or ≥5). Age 
at study enrolment was categorised as 18 - 29, 30 - 39, 40 - 49 and 
≥50 years. We also analysed race (black or other than black, including 
white, Asian and mixed races), nationality (South African or non-South 
African), marital status (single, married or cohabitating, divorced or 
separated, or widowed), highest level of education completed (less 
than Grade 10, Grade 10 - 12, or tertiary education), and employment 
status (full time, part time, self-employed or not employed). Clinical 
characteristics analysed included CD4 count at study enrolment (≤100, 
101 - 250 and >250 cells/µL), cART status at study enrolment (on cART 
or not on cART), self-reported previous Pap smear history (yes or no), 
and results if applicable (negative, low-grade lesion, high-grade lesion 
or invasive cervical cancer, or unknown).
Awareness (a dichotomous variable) regarding Pap smear screen-
ing and HPV was assessed based on whether the woman reported 
knowing what a Pap smear test is and whether she had ever heard 
about HPV, respectively. Perceived risk was assessed based on 
whether the woman indicated that she was very worried, somewhat 
worried or not worried about getting cervical cancer. For the analysis, 
a dichotomous variable was created by combining very worried and 
somewhat worried about getting cervical cancer. Pap screening prac-
tice was based on self-reported screening history before enrolment in 
the study and assessed according to the number of Pap smears over 
the number of years since HIV diagnosis. This was then categorised 
as adequate or not adequate practice according to the national HIV 
treatment guidelines.[8]
Measurement and analysis
Descriptive statistics were used to summarise demographic and 
clinical characteristics at enrolment in the primary study (VICAR 1). 
Categorical variables were described by frequencies and percentages 
using tabulations. For continuous variables, medians and interquartile 
ranges (IQRs) were used where appropriate.
Modified Poisson regression with robust standard errors was used 
to estimate relative risk (RR) to identify predictors at study enrolment 
of awareness, perceived risk and practices related to cervical cancer 
and screening.[13] Factors identified as significant in the univariate 
model (using p<0.2) and a priori variables of importance and 
potential confounders were included in the multivariate model. 
The adjusted relative risk (aRR) and 95% confidence intervals (CIs) 
are reported. All statistical tests performed in the analysis excluded 
missing data. Study data were analysed using Stata version 11 
(StataCorp, USA).
Ethical considerations
The primary study (VICAR 1) was approved by the University of 
the Witwatersrand’s Human Research Ethics Committee (Medical) 
(HREC ref. no. M090516) and for secondary analysis by the Human 
Ethics Committee (Medicine) of the University of North Carolina 
(Human Research Ethics Committee ref. no. 09-1968). Ethical 
clearance for the analysis presented in this article was obtained 
from the University of the Witwatersrand in 2012 (HREC ref. no. 
M120310). To maintain confidentiality, all personal identifiers were 
removed from the data before analysis.
Results
A total of 1 202 HIV-positive women were screened and then 
en rolled in the study. Further information on screening results is 
reported from the primary study (VICAR 1).[11] The median age at 
study enrolment was 38 years (IQR 32 - 43) (Table 1). Of the 1 202 
participants, 160 (13.3%) were divorced/separated or widowed. The 
majority of the women (n=834, 69.4%) had Grade 10 - 12 education, 
and 113 (9.4%) had tertiary education. A total of 125 women (10.4%) 
reported currently drinking alcohol and 125 (10.4%) reported taking 
snuff. A small number reported current smoking (n=42, 3.5%).
Almost all the women (n=1 117, 92.9%) were on cART at study 
enrolment (Table 2). The overall median CD4 count for the group 
was 394 cells/µL (IQR 252 - 577) for the 1 190 participants with data 
evaluated, based on their most recent CD4 level at study enrolment. 
The majority of the small number of study participants (n=84, 7.0%) 
who were not initiated on cART at study enrolment were not eligible 
for cART on the basis of their CD4 count and the HIV treatment 
guidelines at the time.[8]
Previous Pap smear results
A total of 57.2% of the women (688/1 202) self-reported a Pap smear 
screening history before the study, and 80.4% (553/688) of these 
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could recall their result. Of these, 94.6% (523/553) reported that their 
previous Pap smear results were negative, 5.2% (29/553) reported 
low-grade Pap smear results, and 0.2% (1/553) reported high-grade 
Pap smear results.
Awareness, perceived risk, and adequate practice
A total of 71.3% of participants (857/1 202) were aware of Pap smear 
screening, and 18.2% (218/1 201) were aware of HPV. A few women 
(1.9%, 13/688) who reported having a previous Pap smear indicated 
they were not aware of the Pap smear screening test. Only 15.5% of 
participants (186/1 201) indicated awareness of both the Pap smear 
test and HPV (Fig. 1). A total of 1 192 participants responded to the 
question about perceived risk related to cervical cancer. Of these, 912 
(76.5%) were worried or very worried about getting cervical cancer. 
According to the national HIV treatment guidelines based on year 
of HIV diagnosis before the study, 28.6% (304/1 064) had adequate 
cervical cancer screening practice.
Factors associated with awareness and perceived risk
Table 3 presents results of the analysis of association between socio-
demographic and clinical characteristics and awareness related to Pap 
smear screening and HPV. Multivariate analysis indicated that older 
women (aged 40 - 49 years or ≥50 years v. 18 - 29 years) (aRR 1.14, 
95% CI 1.00 - 1.30; aRR 1.29, 95% CI 1.09 - 1.52) and those with 
a higher level of education (Grade 10 - 12 or tertiary v. less than 
Grade  10) (aRR 1.26, 95% CI 1.12 - 1.42; aRR 1.35, 95% CI 1.16 - 
1.56) were more likely than other women in the study to be aware of 
Pap smear screening. Non-South Africans (aRR 0.86, 95% CI 0.74 - 
1.00) and women who did not have a previous history of Pap smear 
screening (aRR 0.36, 95% CI 0.32 - 0.41) were less likely than other 
women in the study to be aware of Pap smear screening. The other 
covariates were not found to be statistically associated with awareness 
of Pap smear screening (Table 3).
Women with a higher level of education (Grade 10 - 12 or tertiary 
v. less than Grade 10) (aRR 2.56, 95% CI 1.57 - 4.15; aRR 2.97, 95% 
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Fig. 1. Survey responses.
Table 1. Sociodemographic characteristics of the study 
participants at enrolment (N=1 202)
Variable n (%)
Age (yr)
Median (IQR) 38 (32 - 43)
18 - 29 161 (13.4)
30 - 39 546 (45.4)
40 - 49 397 (33.0)
≥50 98 (8.2)
Race
Black 1 179 (98.1)
Other 23 (1.9)
Nationality
South African 1 075 (89.4)
Non-South African 112 (9.3)
Information missing 15 (1.3)
Marital status
Single 658 (54.7)
Married/cohabiting 384 (32.0)
Divorced/separated/widowed 160 (13.3)
Education
< Grade 10 229 (19.1)
Grade 10 - 12 834 (69.4)
Tertiary 113 (9.4)
No education 26 (2.2)
Employment
Full time 448 (37.3)
Part time 182 (15.1)
Self-employed 26 (2.2)
Not employed 523 (43.5)
Information missing 23 (1.9)
Drinking alcohol
Yes 125 (10.4)
No 1 077 (89.6)
Smoking
Yes 42 (3.5)
 <5 cigarettes/day 28 (66.7)
 ≥5 cigarettes/day 14 (33.3)
No 1 160 (96.5)
Taking snuff
Yes 125 (10.4)
 <5 times/day 98 (82.4)
 ≥5 times/day 21 (17.7)
No 1 077 (89.6)
Table 2. Clinical characteristics of the study participants at 
enrolment (N=1 202)
Variable n (%)
CD4 count (cells/µL) at study enrolment 
Median (IQR) 394 (252 - 572)
0 - 100 44 (3.7)
101 - 250 249 (20.7)
>251 897 (74.6)
Information missing 12 (1.0)
On cART
Yes 1 117 (92.9)
No 84 (7.0)
Information missing 1 (0.1)
Previous Pap smear screening history
Yes 688 (57.2)
No 514 (42.8)
Previous Pap smear results
Negative 523 (76.0)
Low grade 29 (4.2)
High grade/ICC 1 (0.1)
Information missing 135 (19.6)
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CI 1.67 - 5.30) were more likely than other women in the study to 
be aware of HPV. Women who did not have a previous history of 
Pap smear screening (aRR 0.71, 95% CI 0.55 - 0.92) were less likely than 
other women in the study to be aware of HPV. The other covariates were 
not found to be statistically associated with awareness of HPV (Table 3).
Table 4 presents results of the analysis of association between 
sociodemographic and clinical characteristics and being at risk of 
cervical cancer and practice related to Pap smear screening. Women 
with a higher level of education (Grade 10 - 12 or tertiary v. less than 
Grade 10) (aRR 1.10, 95% CI 1.01 - 1.20; aRR 1.16, 95% CI 1.03 - 
1.31) and those who did not take snuff (aRR 1.14, 95% CI 1.00 - 1.29) 
were more likely than other women in the study to be worried about 
cervical cancer. Women who reported a history of alcohol use (aRR 
0.89, 95% CI 0.82 - 0.97) were less likely than other women in the 
study to be worried about cervical cancer. The other covariates were 
not found to be statistically associated with practice related to Pap 
smear screening (Table 4).
Older women (aged 40 - 49 or ≥50 years v. 18 - 29 years) (aRR 1.63, 
95% CI 1.12 - 2.37; aRR 2.22, 95% CI 1.44 - 3.41), those with a higher 
education (tertiary v. less than Grade 10) (aRR 1.39, 95% CI 1.00 - 
1.93) and those initiated on cART (aRR 1.36, 95% CI 1.00 - 1.85) 
were more likely than other women in the study to have adequate Pap 
smear screening practice according to the HIV treatment guidelines.
Association between awareness and perceived risk  
and adequate practice
Table 5 presents the results of the analysis examining the association 
between awareness, perceived risks and adequate screening practice 
Table 3. Factors associated with awareness of Pap smear screening and HPV
Factor
Pap awareness,
aRR (95% CI)†
HPV awareness,
aRR (95% CI)‡
Age (yr)
18 - 29 Ref Ref
30 - 39 1.11 (0.98 - 1.25) 1.32 (0.88 - 1.97)
40 - 49 1.14 (1.00 - 1.30)* 1.37 (0.90 - 2.08)
≥50 1.29 (1.09 - 1.52)* 0.82 (0.41 - 1.63)
Race
Black Ref -
Other 1.03 (0.91 - 1.16) -
Nationality
South African Ref -
Non-South African 0.86 (0.74 - 1.00)* -
Marital status
Single Ref -
Married/cohabiting 0.99 (0.90 - 1.06) -
Divorced/separated/widowed 1.05 (0.95 - 1.17) -
Education
< Grade 10 Ref Ref
Grade 10 - 12 1.26 (1.12 - 1.42)* 2.56 (1.57 - 4.15)*
Tertiary 1.35 (1.16 - 1.56)* 2.97(1.67 - 5.30)*
No education 0.92 (0.65 - 1.31) 0.53 (0.07 - 3.89)
Employment
Full time Ref Ref
Part time - 1.15 (0.80 - 1.68)
Self-employed - 1.60 (0.88 - 2.91)
Not employed - 1.16 (0.89 - 1.53)
Drinking alcohol
Yes Ref Ref
No 0.98 (0.78 - 1.45) 0.73 (0.53 - 1.01)
Taking snuff
Yes Ref -
No 1.41 (0.99 - 1.09) -
On cART
Yes Ref -
No 1.10 (0.98 - 1.25) -
Previous Pap screening history
Yes Ref Ref
No 0.36 (0.32 - 0.41)* 0.71 (0.55 - 0.92)*
Ref = 1.00; - = not included in the multivariate analysis, not significant in the univariate analysis.
*Statistically significant (p<0.005).
†Adjusted for age, nationality, marital status, education, alcohol, snuff, cART and Pap screening history.
‡Adjusted for age, education, employment, alcohol and Pap screening history. 
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according to the HIV treatment guidelines. Crude and aRR results 
are reported. Models were adjusted for age, education level, and prior 
initiation on cART.
Multivariate analysis indicated that awareness of Pap smear 
screening was associated with adequate screening practice (aRR 
16.18, 95% CI 7.69 - 34.01) according to the HIV treatment 
guidelines. However, awareness of HPV and perception of being at 
risk of cervical cancer were not significantly associated with adequate 
screening practice.
Discussion
Pap smear screening and HPV awareness
Results from our study showed that most (71.3%) HIV-positive 
women in care at a public sector HIV clinic in urban Johannesburg 
reported being aware of Pap smear screening. A study conducted 
among much younger (mean age 22 years) tertiary students in the 
Eastern Cape Province of SA showed similar results, with 70% 
awareness of Pap smear screening among the study partici pants.[14]
Higher education was a common significant factor in all outcomes 
assessed in our study. Low literacy/education has been shown 
to correlate with negative health behaviour and a higher risk of 
morbidity and mortality.[10,15]
Our results also showed that older women were more likely to be 
aware of Pap smear screening and to have adequate cervical cancer 
screening practice according to the HIV treatment guidelines. 
Cervical cancer has traditionally been a disease that mostly affects 
older women, and this age group would have been targeted with 
health education and screening services as part of the national 
screening programme.[10,12]
Our study participants were found to have low levels of HPV 
awareness, further highlighting the urgent need for effective health 
education programmes. Our study was conducted before the HPV 
vaccination programme was initiated in SA. The national HPV 
vaccination programme the country now has may result in wider 
awareness and knowledge regarding HPV in the country. This could 
be through media coverage of the vaccine programme, or women 
with daughters having access to information when interacting with 
the programme.[16]
Table 5. Impact of awareness and perceived risk on practice
Factor
Not adequate 
practice,
n (%)
Adequate 
practice,
n (%) RR (95% CI) aRR (95% CI) †
Awareness of Pap smears
(n=1 063)
Not aware 288 (37.9) 7 (2.3) Ref Ref
Aware 471 (62.1) 297 (97.7) 16.27 (7.78 - 34.04)* 16.18 (7.69 - 34.01)*
Awareness of HPV
(n=1 062)
Not aware 622 (82.1) 252 (82.9) Ref Ref
Aware 136 (17.9) 52 (17.1) 0.96 (0.75 - 1.23) 0.99 (0.77 - 1.27)
Perceived risk
(n=1 053)
Not worried 179 (23.8) 73 (24.1) Ref Ref
Worried 572 (76.2) 230 (75.9) 0.99 (0.79 - 1.24) 1.00 (0.81 - 1.25)
Ref = 1.00.
*Statistically significant (p<0.005).
†Adjusted for age group, education and on cART.
Table 4. Factors associated with Pap smear screening 
practice and perceived risk
Factor
Perceived risk,
aRR (95% CI)†
Practice according 
to HIV treatment 
guidelines,
aRR (95% CI)‡
Age (yr)
18 - 29 Ref Ref
30 - 39 1.18 (0.72 - 1.93) 1.33 (0.92 - 1.92)
40 - 49 1.01 (0.61 - 1.69) 1.63 (1.12 - 2.37)*
≥50 1.09 (0.60 - 2.00) 2.22 (1.44 - 3.41)*
Race
Black - Ref
Other - 1.31 (0.85 - 2.02)
Education
< Grade 10 Ref Ref
Grade 10 - 12 1.10 (1.01 - 1.20)* 0.85 (0.66 - 1.08)
Tertiary 1.16 (1.03 - 1.31)* 1.39 (1.00 - 1.93)*
No education 0.88 (0.64 - 1.22) 0.77 (0.39 - 1.52)
Employment
Full time Ref Ref
Part time 1.06 (0.81 - 1.71) 0.78 (0.58 - 1.06)
Self-employed 1.20 (1.03 - 1.39) 1.30 (0.76 - 2.23)
Not employed 1.09 (1.01 - 1.17) 0.92 (0.75 - 1.14)
Drinking alcohol
Yes Ref Ref
No 0.89 (0.82 - 0.97)* 0.98 (0.76 - 1.27)
Taking snuff
Yes Ref Ref
No 1.14 (1.00 - 1.29)* 1.28 (0.93 - 1.76)
On cART
Yes - Ref
No - 1.36 (1.00 - 1.85)*
Ref = 1.00; - = not included in the multivariate analysis, not significant in the univariate 
analysis.
*Statistically significant (p<0.005).
†Adjusted for age, education, employment, alcohol use and snuff use.
‡Adjusted for age, education, employment, alcohol use, snuff use and cART.
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Perceived risk related to cervical cancer and  
Pap screening
Previous studies found that women’s perceived risk may negatively 
influence screening behaviours and lead to an increased risk of 
morbidity and mortality.[10,17] Women may believe that they are not 
susceptible to the disease, which may lead them to forgo screening, 
thereby missing out on the chance to have the disease detected and 
treated appropriately. Lack of awareness and knowledge about the 
disease and its prevention is seen as an important factor influencing 
women’s perceptions regarding their risk related to the disease.[10,17]
Our study found that a majority (76.5%) of the participants were 
worried about getting cervical cancer. Not taking snuff was one of the 
factors found to increase the likelihood of study participants being 
more worried about cervical cancer. Snuff use, a culturally relevant 
practice in our study setting, is a factor that has not been explored 
extensively in relation to cervical cancer. Nonetheless, it is a risky 
negative behaviour that may negatively influence health outcomes. 
Women who did not use snuff could therefore be expected to be 
more worried about cervical cancer than other women in the study, 
as their non-snuff-taking behaviour may indicate concern about 
negative health behaviour and outcomes. Alcohol use was found 
to decrease the likelihood of being worried about cervical cancer. 
Alcohol consumption is known to adversely influence both health-
related behaviour and health outcomes, but levels of alcohol use 
were not quantified in the study, and this result should therefore be 
interpreted with caution.[18]
Practices related to Pap smear screening
In addition to older women and those with tertiary education, 
women on cART were found to be more likely than other women in 
the study to have adequate cervical cancer screening practice. Women 
on cART have probably been provided with health education and Pap 
smear screening through their encounters with the healthcare system 
during the course of their care and treatment, as recommended in 
the HIV guidelines.
Study limitations
This study has similar limitations to others that have included 
patient questionnaires about sexual and substance abuse history. 
Some individuals may have been too embarrassed to answer study 
questions of a personal nature truthfully. Information bias was 
minimised by using trained interviewers, having a standard operating 
procedure for conducting interviews, and using interviewers fluent 
in the local languages who could interview participants in their own 
language.
Selection bias may exist, as participants could have enrolled in the 
study because they were unwell (lower CD4 cell count), because their 
healthcare provider was particularly worried about their exposure 
to HPV, or because they were worried about cervical cancer and 
therefore willing to participate in a screening study. Since they were 
seeking HIV care and cART,  these patients may be healthier than 
their HIV-positive counterparts who were eligible for cART but not 
in HIV care, or on cART and not seeking further care and treatment. 
Generalisability of our findings to populations at the non-tertiary, 
smaller or rural facilities found throughout SA may be limited, as 
Themba Lethu Clinic is an urban HIV treatment site situated in a 
tertiary hospital.
Conclusions
An important finding was that if participants were aware of Pap smear 
screening they were more likely to have adequate screening practice. 
However, despite high levels of Pap smear screening awareness, low 
screening uptake was noted among our study participants. Examining 
health education programmes related to cervical cancer could 
provide an opportunity to effectively address gaps in knowledge and 
awareness in order to improve screening practice.
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